ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,866, issued on June 16, was assigned to Eli Lilly and Co. (Indianapolis).
"URI agonist/vasodilator" was invented by Michael Patrick Akers (Indianapolis), Chi A. Nguyen (Fishers, Ind.), Chad D. Paavola (Carmel, Ind.), Virender Kumar Sarin (Carmel, Ind.), Nanette Elizabeth Schulte (Indianapolis) and Ranajoy Majumdar (Indianapolis).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic a...